Over the 18-month exploitation project, WEB-RADR 2 has significantly enhanced its mobile application platform and now offers the ability to embed the functionality into systems, applications and websites by use of Application Programming Interfaces (APIs), based on public and European Federation of Pharmaceutical Industries and Associations (EFPIA) requirements. These enhancements have facilitated adoption in eight countries and fostered a successful partnership with the World Health Organisation to continue the roll out the technology in the future.

In addition, bi-directional maps between SNOMED CT and MedDRA terminologies have been successfully completed for frequently used terms. Led by SNOMED International and MedDRA MSSO, the maintenance model of such mappings has been explored, to support implementation after the project. Connectivity protocols with electronic healthcare record (EHR) databases have also been explored within United Kingdom and Danish settings, such that adverse drug reaction (ADR) and regulatory information can be made available in the healthcare record.

Overview of webinars

WEB-RADR 2 Work Package outputs will be showcased across three stakeholder-focused webinars. The webinars will promote project sustainability and display the fantastic collaborative work achieved over the project.

• Webinar 1: WEB-RADR 2 technology and innovation, 22 June 2020 at 14:00-15:00 UK
• Webinar 2: WEB-RADR 2 terminology mappings, 24 June 2020 at 16:00 - 17:00 UK
• Webinar 3: WEB-RADR 2 future opportunities and sustainability, 29 June 2020 at 14:00 - 15:00 UK

Please register your interest in attending the webinars on this page. Registration closes on Friday 19 June 2020. Registered participants will receive connection details before each webinar.

Participants are invited to submit questions during the webinars. Speakers will be given time at the end of each session to continue discussion and address relevant questions. There is a dedicated question and answer session within each webinar.

The webinars will be recorded and uploaded to the WEB-RADR website. Further details will be made available on the WEB-RADR website events page.

Should you have questions about the webinars please contact: WEB-RADR@mhra.gov.uk.

We look forward to welcoming you to the WEB-RADR 2 webinars.

Best wishes,

WEB-RADR Team

-------------------------------------------------------------------------------

Agenda

Webinar 1: WEB-RADR 2 technology and innovation

22 June 2020, 14:00-15:00 UK

Welcome [14:00]

David Lewis, Novartis

Phil Tregunno, MHRA

Platform user needs and requirements [14:05]

Linda Härmark, LAREB

Technology development [14:10]

Kendal Harrison, MHRA

Mobile application overview [14:20]

Kendal Harrison, MHRA

Industry case study: AbbVie e-PV mobile application [14:30]

Calvin Johnson, AbbVie

Application Programming Interfaces within the Danish healthcare setting [14:40]

Mona Vestergaard Laursen, DKMA

Question and answer [14:50]

Concluding remarks [14:55]

Phil Tregunno, MHRA

Close [15:00]

-------------------------------------------------------------------------------

Agenda

Webinar 2: WEB-RADR 2 terminology mappings

24 June 2020, 16:00-17:00 UK

Welcome [16:00]

David Lewis, Novartis

Phil Tregunno, MHRA

Work Package 4: Terminology Mapping And Maintenance [16:05]

Jane Millar, SNOMED International

Patrick Revelle, MedDRA MSSO

Judy Harrison, MedDRA MSSO

Question and answer [16:35]

Concluding remarks [16:55]

Phil Tregunno, MHRA

Close [17:00]

-------------------------------------------------------------------------------

Agenda

Webinar 3: WEB-RADR 2 future opportunities and sustainability

29 June 2020, 14:00-15:00 UK

Welcome [14:00]

David Lewis, Novartis

Phil Tregunno, MHRA

WEB-RADR platform [14:05]

Phil Tregunno, MHRA

Patients and two-way communication tools [14:15]

François Houÿez, EURORDIS

Global pharmacovigilance – Med Safety mobile application [14:25]

Shanthi Pal, WHO

Medical devices [14:35]

Charlotte Goldsmith, MHRA

Tony Sant, MHRA

Question and answer [14:45]

Concluding remarks [14:55]

Phil Tregunno, MHRA

Close [15:00]

-------------------------------------------------------------------------------